Safety Study of PI-0824 to Treat Pemphigus Vulgaris
An Open-Label, Dose-Escalation, Phase I Clinical Study to Assess the Safety of PI-0824 in Patient With Pemphigus Vulgaris Requiring Daily Corticosteroid Therapy An Open-Label, Dose-Escalation, Phase I Clinical Study to Assess the Safety of PI-0824in Patient Wit ...